Correlation Between AGE Old and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both AGE Old and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AGE Old and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AGE Old and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on AGE Old and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AGE Old with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of AGE Old and Cadrenal Therapeutics,.
Diversification Opportunities for AGE Old and Cadrenal Therapeutics,
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AGE and Cadrenal is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding AGE Old and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and AGE Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AGE Old are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of AGE Old i.e., AGE Old and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between AGE Old and Cadrenal Therapeutics,
If you would invest 1,550 in Cadrenal Therapeutics, Common on November 3, 2024 and sell it today you would earn a total of 427.00 from holding Cadrenal Therapeutics, Common or generate 27.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
AGE Old vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| AGE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cadrenal Therapeutics, |
AGE Old and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AGE Old and Cadrenal Therapeutics,
The main advantage of trading using opposite AGE Old and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AGE Old position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| AGE Old vs. MAIA Biotechnology | AGE Old vs. Larimar Therapeutics | AGE Old vs. Lyra Therapeutics | AGE Old vs. Lineage Cell Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |